Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

How cost-effective is breast cancer screening in different EC countries?

van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ.

Eur J Cancer. 1993;29A(12):1663-8.

PMID:
8398290
2.

National Health Service breast screening programme results for 1991-2.

Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L.

BMJ. 1993 Aug 7;307(6900):353-6. Erratum in: BMJ 1993 Aug 28;307(6903):543.

3.

Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature.

Brown ML, Fintor L.

Breast Cancer Res Treat. 1993;25(2):113-8. Review.

PMID:
8347843
4.

Prediction of the effects and costs of breast-cancer screening in Germany.

Beemsterboer PM, de Koning HJ, Warmerdam PG, Boer R, Swart E, Dierks ML, Robra BP.

Int J Cancer. 1994 Sep 1;58(5):623-8.

PMID:
8077045
5.

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.

Paci E, Boer R, Zappa M, de Koning HJ, van Oortmarssen GJ, Crocetti E, Giorgi D, Rosselli del Turco M, Habbema JD.

Eur J Cancer. 1995;31A(3):348-53.

PMID:
7786600
6.

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ.

J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23.

PMID:
7563167
7.

A model for breast cancer screening.

van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ, Collette HJ, Verbeek AL, Geerts AT, Lubbe KT.

Cancer. 1990 Oct 1;66(7):1601-12.

8.

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.

de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ.

Int J Cancer. 1991 Oct 21;49(4):531-7.

PMID:
1917154

Supplemental Content

Support Center